Sharp makes land acquisition to expand cGMP packaging capacity
The purchase is part of $17 million capacity expansion, which is in addition to a wider $43 million investment into the company's Pennsylvania operations
Global pharma contract packaging and clinical supply specialist Sharp has bought a four-acre plot of land directly adjacent to its Blistering Center of Excellence (comprising two commercial pharmaceutical packaging buildings) in Conshohocken, PA.
This land purchase is part of a $17 million capacity expansion, which Sharp said will enable it to add capacity to meet future demand for cGMP packaging services.
The transaction is also part of a wider $43 million investment into the company's Pennsylvania operations, which will increase its blister packaging capacity by more than 35% this year.
To date, the Conshohocken investment includes the construction and fit out of six new primary GMP rooms as well as fit out for secondary packaging and installation of new blister lines.
Only last month, Pennsylvania Governor Tom Wolf announced and supported Sharp's plan to increase manufacturing capacity by upgrading and partially re-purposing some of its four-facility Allentown campus, upgrade and obtain new machinery and equipment for its two-facility Conshohocken site, and make building improvements and obtain new machinery and equipment at its recently acquired 170,000-sq ft. facility in Macungie Borough.
In addition, Sharp expects to receive a $1.25 million state grant and a $140,000 grant to assist with worker training.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance